review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0264-410X(88)80017-3 |
P698 | PubMed publication ID | 3291451 |
P2093 | author name string | Stocker BA | |
P2860 | cites work | Positive selection for loss of tetracycline resistance. | Q34147960 |
Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans | Q34564835 | ||
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines | Q39513114 | ||
Isolation of stable aroA mutants of Salmonella typhi Ty2: properties and preliminary characterisation in mice | Q40797598 | ||
Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and of two strains of Salmonella typhimurium | Q46564311 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | vaccine | Q134808 |
Salmonella typhi | Q22111431 | ||
P304 | page(s) | 141-145 | |
P577 | publication date | 1988-04-01 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Auxotrophic Salmonella typhi as live vaccine | |
P478 | volume | 6 |
Q37123734 | A colanic acid operon deletion mutation enhances induction of early antibody responses by live attenuated Salmonella vaccine strains |
Q36883886 | A safe bacterial microsyringe for in vivo antigen delivery and immunotherapy. |
Q34286908 | A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. |
Q35164813 | A vaccine for tularaemia |
Q39518014 | Aromatic compound-dependent Brucella suis is attenuated in both cultured cells and mouse models. |
Q41916058 | Assessment of immunity against avian colibacillosis induced by an aroA mutant containing increased serum survival gene in broilers |
Q57915185 | Attenuated Bacterial Vaccines |
Q36888904 | Attenuation, persistence, and vaccine potential of an Edwardsiella ictaluri purA mutant. |
Q35222960 | Auxotrophs of Plasmodium falciparum dependent on p-aminobenzoic acid for growth |
Q38034843 | Bacterial vectors for active immunotherapy reach clinical and industrial stages |
Q34469798 | Bacterial virulence, proinflammatory cytokines and host immunity: how to choose the appropriate Salmonella vaccine strain? |
Q40833290 | Behavior of an Aeromonas hydrophila aroA live vaccine in water microcosms |
Q33292511 | Cloning of a sequence ofAquaspirillum magnetotacticumthat complements thearoDgene ofEscherichia coli |
Q37055410 | Common themes in microbial pathogenicity |
Q30453226 | Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine |
Q36065692 | Construction of attenuated Salmonella typhimurium Strain expressing Helicobacter pylori conservative region of adhesin antigen and its immunogenicity |
Q36213903 | Construction of delta aroA his delta pur strains of Salmonella typhi |
Q42237667 | Convergent molecular evolution of genomic cores in Salmonella enterica and Escherichia coli |
Q39227963 | Development of an auxotrophic oral live Shigella flexneri vaccine |
Q34004542 | Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar typhimurium expressing a Porphyromonas gingivalis hemagglutinin |
Q35604978 | Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine |
Q39510762 | Evaluation of Salmonella typhimurium mutants in a model of experimental gastroenteritis |
Q30839901 | Identification of Brucella suis genes affecting intracellular survival in an in vitro human macrophage infection model by signature-tagged transposon mutagenesis |
Q28478365 | In vivo expression of Salmonella enterica serotype Typhi genes in the blood of patients with typhoid fever in Bangladesh |
Q35598060 | Infection with conditionally virulent Streptococcus pneumoniae Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains |
Q37650583 | Intracellular replication is essential for the virulence of Salmonella typhimurium |
Q72209858 | Intranasal immunization with liposomes induces strong mucosal immune responses in mice |
Q37341926 | Large-scale isolation of candidate virulence genes of Pseudomonas aeruginosa by in vivo selection. |
Q38152473 | Live-attenuated bacteria as a cancer vaccine vector |
Q38088794 | New tuberculosis drug development: targeting the shikimate pathway |
Q40744054 | Oral enteric vaccines--clinical trials |
Q39548338 | Oral vaccination |
Q40219808 | Prediction of vaccine candidates against Pseudomonas aeruginosa: An integrated genomics and proteomics approach |
Q30726013 | Preliminary analysis and annotation of the partial genome sequence of Francisella tularensis strain Schu 4. |
Q30358493 | Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines. |
Q33610996 | Role of gamma interferon in late stages of murine salmonellosis |
Q36982528 | Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a |
Q35528270 | Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. |
Q49644946 | Salmonella Vaccines: Conduits for Protective Antigens |
Q36660048 | Salmonella induces the formation of filamentous structures containing lysosomal membrane glycoproteins in epithelial cells |
Q50105772 | Salmonella typhi and S typhimurium derivatives harbouring deletions in aromatic biosynthesis and Salmonella Pathogenicity Island-2 (SPI-2) genes as vaccines and vectors |
Q35102292 | Salmonella typhimurium virulence in a burned-mouse model |
Q38776306 | Strategies for the development of vaccines for typhoid fever, shigellosis, and cholera |
Q24550669 | Targeting the shikimate pathway in the malaria parasite Plasmodium falciparum |
Q42646861 | The aroA gene of Campylobacter jejuni |
Q80042325 | The auxotrophic aroA mutant of Aeromonas hydrophila as a live attenuated vaccine against A. salmonicida infections in rainbow trout (Oncorhynchus mykiss) |
Q42985403 | The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience. |
Q34310210 | Vaccination against bubonic and pneumonic plague |
Q34543536 | Vaccination of chickens with strain CVL30, a genetically defined Salmonella enteritidis aroA live oral vaccine candidate |
Q39649718 | Vaccine development reconsidered |
Q51690362 | Vaccine efficacy of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin against mycoplasmal pneumonia of swine. |
Q28266964 | Vaccines and immunotherapy against Pseudomonas aeruginosa |
Q33769463 | Virulence of Pseudomonas aeruginosa in a murine model of gastrointestinal colonization and dissemination in neutropenia |
Search more.